Skip to main navigation

Main navigation

Company Announcements
Financials
- Financial Reports
- SEC Filings
Share Information
Corporate Governance
Presentations
Analyst Coverage
Calendar
Contact IR
Email Alerts

Find a provider Contact Us

Menu

Home
Company Announcements
Financials
- Financial Reports
- SEC Filings
Share Information
Corporate Governance
Presentations
Calendar
Contact IR
Email Alerts

Financial Reports

Year

Q3 2017 466.2 KB

Q2 2017 302 KB

Q1 2017 496.6 KB

Annual report 2016 354.7 KB

Q3 2016 584.5 KB

Q2 2016 467.5 KB

Q1 2016 386.1 KB

Annual Report 2015 355.3 KB

Q3 2015 478.6 KB

Q2 2015 431.5 KB

Pagination

First page
Previous page
Page 1
Current page 2
Page 3
Next page
Last page

About Us

About Us
Board Of Directors
Careers
Investor Relations
Contact Us

Patients

Find A Provider
How Does it Work?
Our Treatments
News & Events
Knowledge Center
Reimbursement
Video Gallery
Safety Information
Disclaimer

Healthcare Professional

Healthcare Professionals
Our Treatments
Technology
Clinical Research
Video Gallery

Connect with Us

×

Disclaimer

This is BrainsWay’s global website. The global website is not intended for persons in the United States and includes information on clinical indications that were not cleared by the FDA, which are subject to further US regulatory review for safety and efficacy. BrainsWay is cleared by the FDA only for patients with MDD who failed to respond to one or more anti-depressants in the current episode, and for patients with OCD as an adjunct treatment.